Cautious stance on the outlook

13/01/22 -"M&S has delivered good Q3 21/22 sales, mainly driven by the strong Christmas trading performance. The Food business maintained solid momentum, and the C&H also experienced positive growth for ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

13/01/22

Download

You may also be interested by these reports :

06/11/25

Fielmann Group

3Q25 results below consensus expectations – FY25E guidance confirmed

05/11/25

Marks & Spencer

M&S delivered better-than-feared H1 25 results, supported by strong momentum in Food. Adjusted PBT fell 55% YoY due to the April cyber incident that ...

31/10/25

Avolta

Avolta’s Q3 results slightly missed consensus expectations. While growth was robust across all regions, North America continued to experience some ...

30/10/25

Galenica

Galenica’s YTD 2025 sales reached CHF 2,999.7 million, growing by 4.7%. This growth was driven by strong tailwinds from prescription drugs, ...

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue